News
ARAY
0.4385
+9.52%
0.0381
Weekly Report: what happened at ARAY last week (0406-0410)?
Weekly Report · 2d ago
Accuray files Form 3 initial beneficial ownership statement for Chief Commercial Officer Paul Miele
Reuters · 5d ago
Accuray Amends Dedication Capital Consulting Agreement, Cuts Fees
TipRanks · 04/07 13:44
Accuray names Paul Miele as Chief Commercial Officer
TipRanks · 04/06 13:22
Accuray names Paul Miele senior vice president, chief commercial officer
Reuters · 04/06 13:01
ACCURAY APPOINTS PAUL MIELE AS SENIOR VICE PRESIDENT AND CHIEF COMMERCIAL OFFICER
Reuters · 04/06 13:00
Press Release: Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer
Dow Jones · 04/06 13:00
Weekly Report: what happened at ARAY last week (0330-0403)?
Weekly Report · 04/06 10:26
Weekly Report: what happened at ARAY last week (0323-0327)?
Weekly Report · 03/30 10:26
Weekly Report: what happened at ARAY last week (0316-0320)?
Weekly Report · 03/23 10:22
Accuray Announces Transition of Chief Commercial Officer Role
TipRanks · 03/19 20:36
Accuray Chief Commercial Officer Sandeep Chalke to Depart March 31, 2026
Reuters · 03/19 20:03
Weekly Report: what happened at ARAY last week (0309-0313)?
Weekly Report · 03/16 10:21
Weekly Report: what happened at ARAY last week (0302-0306)?
Weekly Report · 03/09 10:22
Weekly Report: what happened at ARAY last week (0223-0227)?
Weekly Report · 03/02 10:21
Accuray Director Steven F. Mayer Acquires Common Shares
Reuters · 02/23 21:10
Weekly Report: what happened at ARAY last week (0216-0220)?
Weekly Report · 02/23 10:21
Accuray Director Steven F. Mayer Acquires Common Shares
Reuters · 02/20 21:10
BTIG Keeps Their Buy Rating on Accuray (ARAY)
TipRanks · 02/20 17:06
RaySearch CEO Flags COVID Hit to Q1 Sales and Orders
Reuters · 02/20 15:46
More
Webull provides a variety of real-time ARAY stock news. You can receive the latest news about Accuray Incorp through multiple platforms. This information may help you make smarter investment decisions.
About ARAY
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.